1887

Abstract

Hepatitis B virus X protein (HBx) is involved in the development of hepatocellular carcinoma (HCC). The HBx sequence is a preferential site of integration into the human genome, leading to the formation of C-terminal-truncated HBx proteins (Ct-HBx). We previously reported that Ct-HBx proteins were able to potentiate cell transformation . Our present goal was to compare the ability of Ct-HBx and full-length HBx (FL-HBx) proteins to develop or enhance HCC in transgenic mice. In the absence of treatment, neither Ct-HBx- nor FL-HBx-transgenic mice developed HCC. In young mice treated with diethylnitrosamine (DEN) at 8 months of age, a significantly higher incidence and number of liver lesions were observed in Ct-HBx mice than in FL-HBx and control mice. The earlier development of tumours in Ct-HBx-transgenic mice was associated with increased liver inflammation. At 10 months, macroscopic and microscopic analyses showed that, statistically, FL-HBx mice developed more liver lesions with a larger surface area than control mice. Furthermore, during DEN-induced initiation of HCC, Ct-HBx- and FL-HBx-transgenic mice showed higher expression of IL-6, TNF-α and IL-1β transcripts, activation of STAT3, ERK and JNK proteins and an increase in cell apoptosis. In conclusion, in DEN-treated transgenic mice, the expression of Ct-HBx protein causes a more rapid onset of HCC than does FL-HBx protein. HBV genome integration leading to the expression of a truncated form of HBx protein may therefore facilitate HCC development in chronically infected patients.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.070680-0
2015-03-01
2019-12-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/96/3/614.html?itemId=/content/journal/jgv/10.1099/vir.0.070680-0&mimeType=html&fmt=ahah

References

  1. Assrir N. , Soussan P. , Kremsdorf D. , Rossignol J. M. . ( 2010; ). Role of the hepatitis B virus proteins in pro- and anti-apoptotic processes. . Front Biosci 15:, 12–24. [CrossRef] [PubMed]
    [Google Scholar]
  2. Bergametti F. , Sitterlin D. , Transy C. . ( 2002; ). Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. . J Virol 76:, 6495–6501. [CrossRef] [PubMed]
    [Google Scholar]
  3. Bock C. T. , Toan N. L. , Koeberlein B. , Song L. H. , Chin R. , Zentgraf H. , Kandolf R. , Torresi J. . ( 2008; ). Subcellular mislocalization of mutant hepatitis B X proteins contributes to modulation of STAT/SOCS signaling in hepatocellular carcinoma. . Intervirology 51:, 432–443. [CrossRef] [PubMed]
    [Google Scholar]
  4. Brandon-Warner E. , Walling T. L. , Schrum L. W. , McKillop I. H. . ( 2012; ). Chronic ethanol feeding accelerates hepatocellular carcinoma progression in a sex-dependent manner in a mouse model of hepatocarcinogenesis. . Alcohol Clin Exp Res 36:, 641–653. [CrossRef] [PubMed]
    [Google Scholar]
  5. Brechot C. , Kremsdorf D. , Soussan P. , Pineau P. , Dejean A. , Paterlini-Brechot P. , Tiollais P. . ( 2010; ). Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. . Pathol Biol (Paris) 58:, 278–287. [CrossRef] [PubMed]
    [Google Scholar]
  6. Fu X. , Tan D. , Hou Z. , Hu Z. , Liu G. , Ouyang Y. , Liu F. . ( 2012; ). The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation. . PLoS ONE 7:, e43204. [CrossRef] [PubMed]
    [Google Scholar]
  7. He G. , Yu G. Y. , Temkin V. , Ogata H. , Kuntzen C. , Sakurai T. , Sieghart W. , Peck-Radosavljevic M. , Leffert H. L. , Karin M. . ( 2010; ). Hepatocyte IKK β/NF-κB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. . Cancer Cell 17:, 286–297. [CrossRef] [PubMed]
    [Google Scholar]
  8. Huo T. I. , Wang X. W. , Forgues M. , Wu C. G. , Spillare E. A. , Giannini C. , Brechot C. , Harris C. C. . ( 2001; ). Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis. . Oncogene 20:, 3620–3628. [CrossRef] [PubMed]
    [Google Scholar]
  9. Iavarone M. , Trabut J. B. , Delpuech O. , Carnot F. , Colombo M. , Kremsdorf D. , Bréchot C. , Thiers V. . ( 2003; ). Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. . J Hepatol 39:, 253–261. [CrossRef] [PubMed]
    [Google Scholar]
  10. Jiang W. , Wang X. W. , Unger T. , Forgues M. , Kim J. W. , Hussain S. P. , Bowman E. , Spillare E. A. , Lipsky M. M. . & other authors ( 2010; ). Cooperation of tumor-derived HBx mutants and p53-249(ser) mutant in regulating cell proliferation, anchorage-independent growth and aneuploidy in a telomerase-immortalized normal human hepatocyte-derived cell line. . Int J Cancer 127:, 1011–1020. [CrossRef] [PubMed]
    [Google Scholar]
  11. Jiang Z. , Jhunjhunwala S. , Liu J. , Haverty P. M. , Kennemer M. I. , Guan Y. , Lee W. , Carnevali P. , Stinson J. . & other authors ( 2012; ). The effects of hepatitis B virus integration into the genomes of hepatocellular carcinoma patients. . Genome Res 22:, 593–601. [CrossRef] [PubMed]
    [Google Scholar]
  12. Jung S. Y. , Kim Y. J. . ( 2013; ). C-terminal region of HBx is crucial for mitochondrial DNA damage. . Cancer Lett 331:, 76–83. [CrossRef] [PubMed]
    [Google Scholar]
  13. Kew M. C. . ( 2011; ). Hepatitis B virus x protein in the pathogenesis of hepatitis B virus-induced hepatocellular carcinoma. . J Gastroenterol Hepatol 26: (Suppl. 1), 144–152. [CrossRef] [PubMed]
    [Google Scholar]
  14. Kremsdorf D. , Soussan P. , Paterlini-Brechot P. , Brechot C. . ( 2006; ). Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. . Oncogene 25:, 3823–3833. [CrossRef] [PubMed]
    [Google Scholar]
  15. Kuang S. Y. , Jackson P. E. , Wang J. B. , Lu P. X. , Muñoz A. , Qian G. S. , Kensler T. W. , Groopman J. D. . ( 2004; ). Specific mutations of hepatitis B virus in plasma predict liver cancer development. . Proc Natl Acad Sci U S A 101:, 3575–3580. [CrossRef] [PubMed]
    [Google Scholar]
  16. Lee J. S. , Chu I. S. , Mikaelyan A. , Calvisi D. F. , Heo J. , Reddy J. K. , Thorgeirsson S. S. . ( 2004; ). Application of comparative functional genomics to identify best-fit mouse models to study human cancer. . Nat Genet 36:, 1306–1311. [CrossRef] [PubMed]
    [Google Scholar]
  17. Lee J. H. , Han K. H. , Lee J. M. , Park J. H. , Kim H. S. . ( 2011; ). Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection. . Clin Vaccine Immunol 18:, 914–921. [CrossRef] [PubMed]
    [Google Scholar]
  18. Li M. , Zhu M. , Li W. , Lu Y. , Xie X. , Wu Y. , Zheng S. . ( 2013; ). Alpha-fetoprotein receptor as an early indicator of HBx-driven hepatocarcinogenesis and its applications in tracing cancer cell metastasis. . Cancer Lett 330:, 170–180. [CrossRef] [PubMed]
    [Google Scholar]
  19. Lin-Marq N. , Bontron S. , Leupin O. , Strubin M. . ( 2001; ). Hepatitis B virus X protein interferes with cell viability through interaction with the p127-kDa UV-damaged DNA-binding protein. . Virology 287:, 266–274. [CrossRef] [PubMed]
    [Google Scholar]
  20. Liu X. , Wang L. , Zhang S. , Lin J. , Zhang S. , Feitelson M. A. , Gao H. , Zhu M. . ( 2008a; ). Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. . Carcinogenesis 29:, 1207–1214. [CrossRef] [PubMed]
    [Google Scholar]
  21. Liu X. , Zhang S. , Lin J. , Zhang S. , Feitelson M. A. , Gao H. , Zhu M. . ( 2008b; ). Hepatitis B virus X protein mutants exhibit distinct biological activities in hepatoma Huh7 cells. . Biochem Biophys Res Commun 373:, 643–647. [CrossRef] [PubMed]
    [Google Scholar]
  22. Ma N. F. , Lau S. H. , Hu L. , Xie D. , Wu J. , Yang J. , Wang Y. , Wu M. C. , Fung J. . & other authors ( 2008; ). COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. . Clin Cancer Res 14:, 5061–5068. [CrossRef] [PubMed]
    [Google Scholar]
  23. Madden C. R. , Finegold M. J. , Slagle B. L. . ( 2001; ). Hepatitis B virus X protein acts as a tumor promoter in development of diethylnitrosamine-induced preneoplastic lesions. . J Virol 75:, 3851–3858. [CrossRef] [PubMed]
    [Google Scholar]
  24. Maeda S. , Kamata H. , Luo J. L. , Leffert H. , Karin M. . ( 2005; ). IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. . Cell 121:, 977–990. [CrossRef] [PubMed]
    [Google Scholar]
  25. Malmassari S. L. , Deng Q. , Fontaine H. , Houitte D. , Rimlinger F. , Thiers V. , Maillere B. , Pol S. , Michel M. L. . ( 2007; ). Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope. . Hepatology 45:, 1199–1209. [CrossRef] [PubMed]
    [Google Scholar]
  26. Min L. , He B. , Hui L. . ( 2011; ). Mitogen-activated protein kinases in hepatocellular carcinoma development. . Semin Cancer Biol 21:, 10–20. [CrossRef] [PubMed]
    [Google Scholar]
  27. Naugler W. E. , Sakurai T. , Kim S. , Maeda S. , Kim K. , Elsharkawy A. M. , Karin M. . ( 2007; ). Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. . Science 317:, 121–124. [CrossRef] [PubMed]
    [Google Scholar]
  28. Nijhara R. , Jana S. S. , Goswami S. K. , Rana A. , Majumdar S. S. , Kumar V. , Sarkar D. P. . ( 2001; ). Sustained activation of mitogen-activated protein kinases and activator protein 1 by the hepatitis B virus X protein in mouse hepatocytes in vivo. . J Virol 75:, 10348–10358. [CrossRef] [PubMed]
    [Google Scholar]
  29. Ogden S. K. , Lee K. C. , Barton M. C. . ( 2000; ). Hepatitis B viral transactivator HBx alleviates p53-mediated repression of alpha-fetoprotein gene expression. . J Biol Chem 275:, 27806–27814.[PubMed]
    [Google Scholar]
  30. Quétier I. , Brezillon N. , Duriez M. , Massinet H. , Giang E. , Ahodantin J. , Lamant C. , Brunelle M. N. , Soussan P. , Kremsdorf D. . ( 2013; ). Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice. . J Hepatol 59:, 285–291. [CrossRef] [PubMed]
    [Google Scholar]
  31. Santos N. P. , Pereira I. C. , Pires M. J. , Lopes C. , Andrade R. , Oliveira M. M. , Colaço A. , Peixoto F. , Oliveira P. A. . ( 2012; ). Histology, bioenergetics and oxidative stress in mouse liver exposed to N-diethylnitrosamine. . In Vivo 26:, 921–929.[PubMed]
    [Google Scholar]
  32. Schmittgen T. D. , Livak K. J. . ( 2008; ). Analyzing real-time PCR data by the comparative C T method. . Nat Protoc 3:, 1101–1108. [CrossRef] [PubMed]
    [Google Scholar]
  33. Schneider C. , Teufel A. , Yevsa T. , Staib F. , Hohmeyer A. , Walenda G. , Zimmermann H. W. , Vucur M. , Huss S. . & other authors ( 2012; ). Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. . Gut 61:, 1733–1743. [CrossRef] [PubMed]
    [Google Scholar]
  34. Seki E. , Brenner D. A. , Karin M. . ( 2012; ). A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. . Gastroenterology 143:, 307–320. [CrossRef] [PubMed]
    [Google Scholar]
  35. Shirakata Y. , Koike K. . ( 2003; ). Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential. . J Biol Chem 278:, 22071–22078. [CrossRef] [PubMed]
    [Google Scholar]
  36. Sirma H. , Giannini C. , Poussin K. , Paterlini P. , Kremsdorf D. , Bréchot C. . ( 1999; ). Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. . Oncogene 18:, 4848–4859. [CrossRef] [PubMed]
    [Google Scholar]
  37. Sung W. K. , Zheng H. , Li S. , Chen R. , Liu X. , Li Y. , Lee N. P. , Lee W. H. , Ariyaratne P. N. . & other authors ( 2012; ). Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. . Nat Genet 44:, 765–769. [CrossRef] [PubMed]
    [Google Scholar]
  38. Sze K. M. , Chu G. K. , Lee J. M. , Ng I. O. . ( 2013; ). C-terminal truncated hepatitis B virus x protein is associated with metastasis and enhances invasiveness by C-Jun/matrix metalloproteinase protein 10 activation in hepatocellular carcinoma. . Hepatology 57:, 131–139. [CrossRef] [PubMed]
    [Google Scholar]
  39. Tanaka Y. , Kanai F. , Ichimura T. , Tateishi K. , Asaoka Y. , Guleng B. , Jazag A. , Ohta M. , Imamura J. . & other authors ( 2006; ). The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. . Oncogene 25:, 633–642.[PubMed] [CrossRef]
    [Google Scholar]
  40. Toh S. T. , Jin Y. , Liu L. , Wang J. , Babrzadeh F. , Gharizadeh B. , Ronaghi M. , Toh H. C. , Chow P. K. . & other authors ( 2013; ). Deep sequencing of the hepatitis B virus in hepatocellular carcinoma patients reveals enriched integration events, structural alterations and sequence variations. . Carcinogenesis 34:, 787–798. [CrossRef] [PubMed]
    [Google Scholar]
  41. Tu H. , Bonura C. , Giannini C. , Mouly H. , Soussan P. , Kew M. , Paterlini-Bréchot P. , Bréchot C. , Kremsdorf D. . ( 2001; ). Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. . Cancer Res 61:, 7803–7810.[PubMed]
    [Google Scholar]
  42. Verna L. , Whysner J. , Williams G. M. . ( 1996; ). N-nitrosodiethylamine mechanistic data and risk assessment: bioactivation, DNA-adduct formation, mutagenicity, and tumor initiation. . Pharmacol Ther 71:, 57–81. [CrossRef] [PubMed]
    [Google Scholar]
  43. Waris G. , Huh K. W. , Siddiqui A. . ( 2001; ). Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. . Mol Cell Biol 21:, 7721–7730. [CrossRef] [PubMed]
    [Google Scholar]
  44. Wei C. , Ni C. , Song T. , Liu Y. , Yang X. , Zheng Z. , Jia Y. , Yuan Y. , Guan K. . & other authors ( 2010; ). The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. . J Immunol 185:, 1158–1168. [CrossRef] [PubMed]
    [Google Scholar]
  45. Xia L. , Huang W. , Tian D. , Zhu H. , Zhang Y. , Hu H. , Fan D. , Nie Y. , Wu K. . ( 2012; ). Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. . J Hepatol 57:, 600–612. [CrossRef] [PubMed]
    [Google Scholar]
  46. Xiang W. Q. , Feng W. F. , Ke W. , Sun Z. , Chen Z. , Liu W. . ( 2011; ). Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway. . J Hepatol 54:, 26–33. [CrossRef] [PubMed]
    [Google Scholar]
  47. Yip W. K. , Cheng A. S. , Zhu R. , Lung R. W. , Tsang D. P. , Lau S. S. , Chen Y. , Sung J. G. , Lai P. B. . & other authors ( 2011; ). Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development. . PLoS ONE 6:, e22888. [CrossRef] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.070680-0
Loading
/content/journal/jgv/10.1099/vir.0.070680-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error